Bath & Body Works, Inc. (NYSE:BBWI) Shares Bought by Everett Harris & Co. CA

Everett Harris & Co. CA grew its stake in Bath & Body Works, Inc. (NYSE:BBWI) by 1.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 49,140 shares of the company’s stock after purchasing an additional 725 shares during the quarter. Everett Harris & Co. CA’s holdings in Bath & Body Works were worth $1,569,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of the stock. Anomaly Capital Management LP acquired a new position in Bath & Body Works in the 2nd quarter valued at $113,995,000. Lone Pine Capital LLC lifted its stake in shares of Bath & Body Works by 15.8% in the second quarter. Lone Pine Capital LLC now owns 11,315,515 shares of the company’s stock worth $441,871,000 after buying an additional 1,547,399 shares in the last quarter. Vanguard Group Inc. boosted its position in Bath & Body Works by 4.2% during the first quarter. Vanguard Group Inc. now owns 27,398,192 shares of the company’s stock worth $1,370,458,000 after acquiring an additional 1,102,124 shares during the last quarter. Interval Partners LP grew its stake in Bath & Body Works by 230.0% during the 2nd quarter. Interval Partners LP now owns 1,280,593 shares of the company’s stock valued at $50,007,000 after acquiring an additional 892,488 shares in the last quarter. Finally, Ceredex Value Advisors LLC purchased a new position in Bath & Body Works in the 2nd quarter worth approximately $25,867,000. Institutional investors and hedge funds own 95.14% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on BBWI. Robert W. Baird reduced their price objective on Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating on the stock in a research report on Thursday, August 29th. BMO Capital Markets reissued an “outperform” rating and set a $50.00 price target (down previously from $52.00) on shares of Bath & Body Works in a research report on Thursday, August 29th. Telsey Advisory Group restated an “outperform” rating and set a $42.00 price objective on shares of Bath & Body Works in a research report on Thursday, September 26th. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Bath & Body Works from $57.00 to $54.00 and set a “buy” rating on the stock in a report on Monday, August 26th. Finally, Bank of America decreased their price objective on Bath & Body Works from $54.00 to $45.00 and set a “buy” rating on the stock in a report on Thursday, August 29th. Eight investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $42.35.

Insiders Place Their Bets

In related news, CEO Gina Boswell bought 6,000 shares of the company’s stock in a transaction that occurred on Wednesday, October 9th. The shares were purchased at an average cost of $29.64 per share, with a total value of $177,840.00. Following the transaction, the chief executive officer now directly owns 242,987 shares of the company’s stock, valued at approximately $7,202,134.68. This represents a 0.00 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.27% of the stock is owned by corporate insiders.

Bath & Body Works Stock Performance

BBWI stock opened at $31.94 on Friday. Bath & Body Works, Inc. has a fifty-two week low of $26.20 and a fifty-two week high of $52.99. The company’s 50 day moving average price is $30.92 and its 200 day moving average price is $38.50. The firm has a market capitalization of $7.13 billion, a price-to-earnings ratio of 8.23, a PEG ratio of 0.94 and a beta of 1.77.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. The business had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.54 billion. Equities analysts forecast that Bath & Body Works, Inc. will post 3.18 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, September 6th. Shareholders of record on Friday, August 23rd were paid a $0.20 dividend. The ex-dividend date was Friday, August 23rd. This represents a $0.80 annualized dividend and a yield of 2.50%. Bath & Body Works’s dividend payout ratio is currently 20.62%.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.